What is CATX (CATX) stock price today?

CATX (CATX) is currently trading at $3.00, up 1.01% today.

What is CATX P/E ratio?

CATX's P/E ratio is -2.59. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is CATX return on equity (ROE)?

CATX's return on equity (ROE) is -49.76%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is CATX's market cap?

CATX has a market capitalization of $342.14M.

ASE · —

CATX (CATX) Stock

$3.00 +1.01% ASE: CATX —

Valuation

Metric	Value
Price	$3.00
Market Cap	$342.14M
P/E Ratio	-2.59
P/B Ratio	1.35
P/S Ratio	498.43
EPS (TTM)	$-1.40
52-Week High	$6.16
52-Week Low	$1.96
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-49.76%
ROA	-38.58%
ROCE	-55.07%
Gross Margin	-3.58%
Operating Margin	-208.72%
Net Margin	-193.27%
Debt/Equity	0.01
Current Ratio	5.10

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$11.0M	$7.0M	$1.0M	$0	$0
Operating Profit	$-7.0M	$-15.0M	$-41.0M	$10.0M	$-114.0M
Net Profit	$-7.0M	$-15.0M	$-47.0M	$-79.0M	$-103.0M
EPS	$-0.13	$-0.27	$-0.85	$-1.23	$-1.40
Op Margin	-68.5%	-213.7%	-2855.0%	—	—

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$67.0M	$58.0M	$98.0M	$341.0M	$267.0M
Total Liabilities	$3.0M	$3.0M	$23.0M	$50.0M	$60.0M
Cash	$60.0M	$21.0M	$9.0M	$62.0M	$31.0M
Borrowings	$1.0M	$0	$3.0M	$4.0M	$2.0M

Latest News

Perspective Therapeutics Names Paul Lyne Chief Science Officer as Co-Founder Michael Schultz Moves to Advisory Role MT Newswires · Jul 8, 2026 Perspective Therapeutics Appoints Paul Lyne, Ph.D., as Chief Science Officer; Co-Founder Michael K. Schultz, Ph.D., Transitions to Senior Scientific Advisor GlobeNewswire · Jul 8, 2026 Perspective Therapeutics (CATX) Reports Encouraging Early Data Across Multiple Radiopharmaceutical Trials Insider Monkey · Jul 5, 2026 Perspective Therapeutics doses first brain tumor patient in expanded radiopharmaceutical trial Proactive · Jun 3, 2026 Perspective Therapeutics Doses First Meningioma Patient in Phase 1/2a Study Cohort MT Newswires · Jun 3, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-8.0M	$-12.0M	$-37.0M	$-18.0M	$-82.0M
Investing Cash Flow	$-1.0M	$-58.0M	$23.0M	$-273.0M	$28.0M
Financing Cash Flow	$0	$0	$0	$289.0M	$0
Net Cash Flow	$-8.0M	$0	$-47.0M	$52.0M	$-31.0M
Free Cash Flow	$-8.0M	$-12.0M	$-38.0M	$-73.0M	$-95.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	—
FCF Yield	-37.45%
Quick Ratio	8.75
Interest Coverage	—
Return 1Y	-32.18%
Return 3Y	-52.42%
Return 5Y	-57.64%

Ownership

Insiders Held10.81%

Institutions Held77.43%

Institutions Float Held86.81%

Institutional Holder	Shares	Report Date
TCG Crossover Management, LLC	7,915,567	2026-03-31
Commodore Capital Lp	6,336,782	2026-03-31
Avidity Partners Management, LP	6,049,999	2026-03-31
Blackrock Inc.	5,348,561	2026-03-31
Opaleye Management Inc.	4,675,000	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AVR	$8.28	+0.00%	-2.56	$304.61M	0.00%
ELMD	$39.48	-0.95%	32.25	$326.90M	0.00%
HSDT	$1.69	+0.60%	-1.25	$98.67M	0.00%
IVVD	$0.55	+3.10%	-3.53	$162.51M	0.00%
MXCT	$1.18	+6.31%	-2.55	$126.40M	0.00%

About CATX

CATX is led by CEO Johan Spoor, employs 138 people, headquartered in US, publicly traded since 2005.

CATX stock trades at $3.00 with a market capitalization of $342.14M. The stock is valued at a price-to-earnings (P/E) ratio of -2.59, price-to-book of 1.35, price-to-sales of 498.43. Over the past 52 weeks the stock has ranged between $1.96 and $6.16, and currently trades 51.3% below its 52-week high.

On profitability, CATX generates a return on equity (ROE) of -49.76%, return on capital employed of -55.07%, an operating margin of -208.72%, a net profit margin of -193.27%.

Related — Stocks

BNY — $152.52 -2.54% CIEN — $412.39 +2.14% CBRS — $188.61 -5.28% HEI.A AIRCRAFT ENGINES & ENGINE PARTS $216.35 +0.00% LEN.B GENERAL BLDG CONTRACTORS - RESIDENTIAL BLDGS $80.32 +0.00% WSO.B WHOLESALE-HARDWARE & PLUMBING & HEATING EQUIPMENT & SUPPLIES $453.37 +0.00% MKC.V MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS $51.78 +0.00% MOG.B MISC INDUSTRIAL & COMMERCIAL MACHINERY & EQUIPMENT $322.00 +0.00% MOG.A MISC INDUSTRIAL & COMMERCIAL MACHINERY & EQUIPMENT $307.91 +0.00% UHAL.B SERVICES-AUTO RENTAL & LEASING (NO DRIVERS) $45.71 +0.00% TAP.A MALT BEVERAGES $47.89 +0.00% VSXY — $88.68 +0.50%

Screens featuring this stock

High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks All stock screens

Run Stock Screener Investing Guides